Potential roles of brain barrier dysfunctions in the early stage of Alzheimer's disease

Brain Research Bulletin
Wen-Xuan JianNai-Hong Chen

Abstract

Though Alzheimer's disease (AD) has been studied for more than a century, to date, no drug has provided a definitive cure. The slow development of the disease and the time lag between pathological changes and the appearance of symptoms make AD difficult to diagnose and result in a missed window of opportunity for effective treatment. Currently, there is still no effective treatment for the late stage of AD, though delayed onset or attenuation of symptoms is possible in the early stages of the disease. The brain barrier is composed of the blood-brain barrier and blood-CSF barrier and is a composite structure of highly selectivity permeability vessels and capillaries in the CNS. Dysfunction of the brain barrier has been confirmed in the late stage of AD; however, whether this dysfunction aggravates the development of AD in the early stage has not been investigated. In this mini-review, we review the basic structure of the brain barrier, including the various protein components and related cytokines and attempt to identify how these might potentially contribute to brain barrier dysfunction in the early stages of AD.

Citations

Feb 2, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Shane A Liddelow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Related Papers

Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics
Takeshi Tabira
Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Margherita GrassoMichela A Denti
Central Asian Journal of Global Health
Sholpan AskarovaJames C-M Lee
© 2022 Meta ULC. All rights reserved